SciSparc (Nasdaq: SPRC) Enters Into Non-Binding Letter of Intent to Sell a 50% interest in its Subsidiary that Owns an Amazon Top Seller Brand

TEL AVIV, Israel, Dec. 14, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that it has entered into a non-binding letter of intent (“LOI”) for the sale of a 50% interest […]

Mill City Ventures III, Ltd. (NASDAQ:MCVT) Provides Short-Term Loan to Mustang Litigation Funding

MINNEAPOLIS, MN / ACCESSWIRE / December 14, 2022 / Mill City Ventures III, Ltd. (“Mill City”) (NASDAQ:MCVT), a specialty short-term finance and non-bank lender, announced today that, in accordance with its previously announced letter of intent regarding a proposed merger transaction with Mustang Funding, LLC dba Mustang Litigation Funding (“Mustang”), it has entered into a $5 […]

Jeffs’ Brands (Nasdaq: JFBR) Enters Into Non-Binding Agreement to Acquire 50% of a Company that Owns an Amazon Top Selling Brand

Tel Aviv, Israel, Dec. 14, 2022 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (the “Company”) (Nasdaq: JFBR), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that it has entered into a non-binding letter of intent (“LOI”) with SciSparc Ltd. (“SciSparc”) (Nasdaq: SPRC), for the purchase of 50% of SciSparc’s wholly owned subsidiary, SciSparc […]

Bruush Oral Care Inc. Announces Closing of $3.0 Million Private Placement

VANCOUVER, BC / ACCESSWIRE / December 9, 2022 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the “Company”) a direct-to-consumer leader in the oral care category, today closed its previously announced private placement pursuant to a securities purchase agreement with institutional investors for aggregate gross proceeds of approximately $3.0 million, before deducting fees to the placement agent and […]

Laser Photonics (NASDAD:LASE) Participates in the 2022 DoD Maintenance Symposium

ORLANDO, FL / ACCESSWIRE / December 13, 2022 / Laser Photonics Corporation (NASDAQ:LASE), (“LPC”), a leading global developer of Cleantech laser systems for laser cleaning and other materials applications, today announced it is a first-time participant in the Defense Maintenance Symposium from December 12 -15, 2022 in Orlando, FL. Wayne Tupuola, CEO of Laser Photonics commented: […]

Brüush (NASDAQ:BRSH) Electric Toothbrush to be a Featured Item on Home Shopping Channel TSC

VANCOUVER, BC / ACCESSWIRE / December 13, 2022 / Bruush Oral Care Inc. (NASDAQ:BRSH) (“Brüush” or the “Company”), “) a direct-to-consumer leader in the oral care category, announced today that it will be participating in a one-day sales campaign on the home shopping channel, Today’s Shopping Choice (“TSC”), on Friday December 16, 2022. This will be the […]

Splash Beverage Group (NYSE American: SBEV) to Present at the Emerging Growth Conference December 14, 2022

Fort Lauderdale, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today announced that Robert Nistico, Chairman and CEO, is scheduled to present virtually at the Emerging Growth Conference on Wednesday, December 14 at 10:50 AM ET.  The presentation is expected to […]

Jupiter Wellness (Nasdaq:JUPW) Approved for Dual Listing on Upstream

JUPITER, FL / ACCESSWIRE / December 13, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW), a wellness company focused on hair, skin, and sexual wellness announced today its approval to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex (“Horizon”) and MERJ Exchange Limited (“MERJ”). Trading begins on Upstream […]

Pasithea Therapeutics (Nasdaq: KTTA) Announces Comprehensive Settlement Agreement with the Camac Group

MIAMI BEACH, Fla., Dec. 12, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders, today announced that it has reached a comprehensive Settlement and Cooperation Agreement (“the Agreement”) with Concord IP2 Ltd., […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.